Guanglin Wang

Dr. Guanglin Wang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2024 in Surface and Coatings Technology
Verified
Journal Article
Closed access
ZWZiyi Wang
Ziyi Wang
GWGuanglin Wang
Guanglin Wang
ZSZiheng Song
Ziheng Song
SLShuxin Liu
Shuxin Liu
YZYan Zhou
Yan Zhou
CMChao Meng
Chao Meng

17 April 2023 in Small
Verified
Journal Article
Open access
ZGZilu Ge
Zilu Ge
WLWei Li
Wei Li
RZRenliang Zhao
Renliang Zhao
WXWei Xiong
Wei Xiong
DWDong Wang
Dong Wang
GWGuanglin Wang
Guanglin Wang
Tendon stem/progenitor cells (TSPCs) therapy is a promising strategy for enhancing cell matrix and collagen synthesis, and regulating the metabolism of the tendon microenvironment during tendon injury repair. Nevertheless, the barren microenvironment and gliding shear of tendon cause insufficient nutrition supply, damage, and aggregation of injected TSPCs around tendon tissues, which severely hinders their clinical application in tendinopathy. In this study, a TSPCs delivery system is developed by encapsulating TSPCs within a DNA hydrogel (TSPCs‐Gel) as the DNA hydrogel offers an excellent artificial extracellular matrix (ECM) microenvironment by providing nutrition for proliferation and protection against shear forces. This delivery method restricts TSPCs to the tendons, significantly extending their retention time. It is also found that TSPCs‐Gel injections can promote the healing of rat tendinopathy in vivo, where cross‐sectional area and load to failure of injured tendons in rats are significantly improved compared to the free TSPCs treatment group at 8 weeks. Furthermore, the potential healing mechanism of TSPCs‐Gel is investigated by RNA‐sequencing to identify a series of potential gene and signaling pathway targets for further clinical treatment strategies. These findings suggest the potential pathways of using DNA hydrogels as artificial ECMs to promote cell proliferation and protect TSPCs in TSPC therapy.

29 March 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
CDChangchao Dong
Changchao Dong
GTGang Tan
Gang Tan
GZGuangyan Zhang
Guangyan Zhang
WLWei Lin
Wei Lin
GWGuanglin Wang
Guanglin Wang
The process of bone regeneration involves the interaction of the skeletal, blood, and immune systems. Bone provides a solid barrier for the origin and development of immune cells in the bone marrow. At the same time, immune cells secrete related factors to feedback on the remodeling of the skeletal system. Pathological or traumatic injury of bone tissue involves changes in blood supply, cell behavior, and cytokine expression. Immune cells and their factors play an essential role in repairing foreign bodies in bone injury or implantation of biomaterials, the clearance of dead cells, and the regeneration of bone tissue. This article reviews the bone regeneration application of the bone tissue repair microenvironment in bone cells and immune cells in the bone marrow and the interaction of materials and immune cells.

21 March 2024 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
QFQian Fang
Qian Fang
DWDong Wang
Dong Wang
WLWei Lin
Wei Lin
ZGZilu Ge
Zilu Ge
XDXiangtian Deng
Xiangtian Deng
GWGuanglin Wang
Guanglin Wang

16 December 2023 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YYYaqin Yuan
Yaqin Yuan
ZZZhen Zhang
Zhen Zhang
JCJinlong Cao
Jinlong Cao
XZXiaowen Zhao
Xiaowen Zhao
LYLin Ye
Lin Ye
GWGuanglin Wang
Guanglin Wang

2 August 2023 in Nano Energy
Verified
Journal Article
Closed access
ZGZilu Ge
Zilu Ge
YQYanxiu Qiao
Yanxiu Qiao
WZWeiwei Zhu
Weiwei Zhu
YXYutao Xu
Yutao Xu
QFQian Fang
Qian Fang
XHXiaoran Hu
Xiaoran Hu